Bridgeway Capital Management, LLC Io Biotech, Inc. Transaction History
Bridgeway Capital Management, LLC
- $4.24 Billion
- Q4 2024
A detailed history of Bridgeway Capital Management, LLC transactions in Io Biotech, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 174,000 shares of IOBT stock, worth $160,080. This represents 0.0% of its overall portfolio holdings.
Number of Shares
174,000
Previous 199,623
12.84%
Holding current value
$160,080
Previous $209,000
23.44%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding IOBT
# of Institutions
27Shares Held
19.7MCall Options Held
0Put Options Held
0-
Vivo Capital, LLC Palo Alto, CA6.17MShares$5.68 Million1.11% of portfolio
-
Novo Holdings Hellerup, G73.35MShares$3.09 Million0.25% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.34MShares$2.15 Million0.14% of portfolio
-
Marshall Wace, LLP London, X02.11MShares$1.94 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.65MShares$1.52 Million0.0% of portfolio
About IO Biotech, Inc.
- Ticker IOBT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,815,300
- Market Cap $26.5M
- Description
- IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...